Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy

Molecular Diagnosis and Therapy

Volumn 37, Issue 12, 2014, Pages 1181-1186

  Puzziello, Alessandro ^a   Carrano, Mario ^b   Angrisani, Elisabetta ^b   Marotta, Vincenzo ^c   Faggiano, Antongiulio ^c   Zeppa, Pio ^a   Vitale, Mario ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Benign nodular goiter; Levothyroxine; Thyroid; Ultrasonography

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; NODULAR GOITER; SUBCLINICAL HYPERTHYROIDISM; THYROID NODULE; THYROTROPIN BLOOD LEVEL; TUMOR GROWTH; TUMOR VOLUME; DISEASE COURSE; DRUG EFFICACY; HORMONAL THERAPY; HYPERTHYROIDISM; LEVOTHYROXINE NON SUPPRESSIVE THERAPY; MALE; BLOOD; MIDDLE AGED;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; THYROID NODULE; THYROXINE;

EID: 84940946953     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/s40618-014-0128-z     Document Type: Article

References (28)

1. Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493
2. Tonacchera M, Pinchera A, Vitti P (2010) Assessment of nodular goitre. Best Pract Res Clin Endocrinol Metab 24:51–61
3. Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840
4. Astwood EB, Cassidy CE, Aurbach GD (1960) Treatment of goiter and thyroid nodules with thyroid. JAMA 174:459–464
5. Shimaoka K, Sokal JE (1974) Suppressive therapy of nontoxic goiter. Am J Med 57:576–583
6. La Rosa GL, Lupo L, Giuffrida D et al (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8
7. Lima N, Knobel M, Cavaliere H et al (1997) Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691–697
8. Zelmanovitz F, Genro S, Gross JL (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881–3885
9. Gharib H, James EM, Charboneau JW et al (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70–75
10. Cheung PS, Lee JM, Boey JH (1989) Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 13:818–821
11. Reverter JL, Lucas A, Salinas I et al (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28
12. Larijani B, Pajouhi M, Bastanhagh MH et al (1999) Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial. Endocr Pract 5:251–256
13. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M (1994) Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 18:495–498
14. Papini E, Petrucci L, Guglielmi R et al (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780–783
15. Uzzan B, Campos J, Cucherat M et al (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289
16. Koc M, Ersoz HO, Akpinar I et al (2002) Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628
17. Grussendorf M, Reiners C, Paschke R, Wegscheider K (2012) Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 96:2786–2795
18. Fine-needle aspiration cytology (FNAC). Guidelines for the management of thyroid cancer. 2nd edition. Royal College of Physicians, London: Perros: 9-10
19. Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68
20. Kuma K, Matsuzuka F, Kobayashi A et al (1992) Outcome of long standing solitary thyroid nodules. World J Surg 16:583–587
21. Knudsen N, Bulow I, Laurberg P et al (2002) Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol (Oxf) 57:71–76
22. Knudsen N, Bulow I, Laurberg P et al (2001) Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol (Oxf) 55:41–46
23. Kristensen HL, Vadstrup S, Knudsen N, Siersbaek-Nielsen K (1995) Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake. J Endocrinol Invest 18:41–43
24. Hegedus L, Rasmussen N, Ravn V et al (1988) Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism 37:229–233
25. Knudsen N, Bulow I, Laurberg P et al (2002) Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Eur J Endocrinol 146:39–43
26. Sapio MR, Guerra A, Marotta V et al (2011) High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. J Clin Endocrinol Metab 96:E916–E919
27. Marotta V, Guerra A, Sapio MR et al (2010) Growing thyroid nodules with benign histology and RET rearrangement. Endocr J 57:1081–1087
28. Marotta V, Guerra A, Sapio MR et al (2010) Are RET/PTC rearrangements in benign thyroid nodules of biological significance? Thyroid 20:1191–1192